Colorectal Cancer Screening by Fecal Occult Blood Testing: Results of a Population-Based Experience

Bertario L. , Russo A. , Crosignani P. , Sala P. , Spinelli P. , Pizzetti P. , Andreola S. , Berrino F. : Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Eur. J. Cancer, 35: 973–977, 1999.

Boon M.E. , Beck S. , Wijsman-Grootendorst A. : Involving the general practitioners in screening for cervical cancer. Cytopathology, 5: 69–75, 1994.

Castiglione G. , Zappa M. , Grazzini G. , Sani C. , Mazzotta A. , Mantellini P. , Ciatto S. : Cost analysis in a population-based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J. Med. Screen., 4: 142–146, 1997.

De Angelis R. , Valente F. , Frova L. , Verdecchia A. , Gatta G. , Chessa E. , Berrino F. : Trends of colorectal cancer incidence and prevalence in Italian regions. Tumori, 84: 1–8, 1998.

European Group for Colorectal Cancer Screening: Recommendation to include colorectal cancer screening in public health policy. J. Med. Screen., 6: 80–81, 1999.

Faivre J. , Tazi M.A. , El Mrini T. , Lejeune C. , Benhamiche A.M. , Dassonville F. : Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br. J. Cancer, 79: 680–683, 1999.

Garvican L. : Planning for a possible national colorectal cancer screening programme. J. Med. Screen., 5: 187–194, 1998.

Gnauck R. : Screening for colon cancer in Germany. Tumori, 81(suppl.): 30–37, 1995.

Hardcastle J.D. , Chamberlain J.O. , Robinson M.H.E. , Moss S.M. , Amar S.S. , Balfour T.W. , James P.D. , Mangham C.M. : Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet, 348: 1472–1477, 1996.

Hardcastle J.D. , Farrands P.A. , Balfour T.W. , Chamberlain J. , Amar S.S. , Sheldon M.G. : Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet, 2: 1–4, 1983.

Joseph A. : Compliance with fecal occult blood testing: the role of restrictive diet. Am. J. Public Health, 78: 839–841, 1988.

Kronborg O. , Fenger C. , Olsen J. , Jorgensen O.D. , Sandergaard O. : Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet, 348: 1467–1471, 1996.

Lallemand R.C. , Vakil P.A. , Pearson P. , Box V. : Screening for asymptomatic bowel cancer in general practice. Br. Med. J., 288: 31–33, 1984.

Launoy G. , Veret J.L. , Richir B. , Reaud J.M. , Ollivier V. , Valla A. , Gignoux M. : Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur. J. Cancer Prev., 2: 229–232, 1993.

Lazovich D. , Weiss N.S. , Stevens N.G. , White E. , McKnight B. , Wagner E.H. : A case-control study to evaluate efficacy of screening for faecal occult blood. J. Med. Screen., 2: 84–89, 1995.

Mandel J.S. , Bond J.H. , Church T.R. , Snover D.C. , Bradley G.M. , Schuman L.M. , Ederer F. : Reducing mortality from colorectal cancer by screening for faecal occult blood. N. Eng. J. Med., 328: 1365–1371, 1993.

Mandel J.S. , Church T.R. , Ederer P. , Bond J.H. : Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl. Cancer Inst., 91: 434–437, 1999.

Ponz de Leon M. , Sant M. , Micheli A. , Sacchetti C. , Di Gregorio C. , Fante R. , Zanghieri G. , Melotti G. , Gatta G. : Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer, 69: 626–635, 1992.

Robinson M.H. , Marks C.G. , Farrands P.A. , Bostock K. , Hardcastle J.D. : Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up. Br. J. Surg., 83: 500–501, 1996.

Robinson M.H. , Pye G. , Thomas W.M. , Hardcastle J.D. , Mangham C.M. : Haemoccult screening for colorectal cancer: the effect of dietary restrictions on compliance. Eur. J. Surg. Oncol., 20: 545–548, 1994.

Saito H. , Soma Y. , Koeda J. , Wada T. , Kawaguchi H. , Sobue T. , Aisawa T. , Yoshida Y. : Reduction in risk of mortality by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int. J. Cancer, 61: 465–469, 1995.

Saito H. , Yoshida Y. : Mass screening: Japanese perspective. In: Prevention and early detection of colorectal cancer, Young G.P. , Rozen P. , Levin B. (Eds.), pp. 301–311, W.B. Saunders, London, 1996.

Selby J.V. , Friedman G.D. , Quesenberry C.P. , Weiss N.S. : Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann. Intern. Med., 118: 1–6, 1993.

Vernon S.W. : Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst., 89: 406–422, 1997.

Wahrendorf J. , Robra B.P. , Wiebelt H. , Oberhausen R. , Weiland M. , Dhom G. : Effectiveness of colorectal cancer screening: result from a population-based case-control evaluation in Saarland, Germany. Eur. J. Cancer Prev., 2: 221–227, 1993.

Zanetti R. , Crosignani P. , Rosso S. : Registro tumori toscano. In: Il cancro in Italia. I dati di incidenza dei registri tumori 1988–1992. Vol. 2, pp. 306–307, Il Pensiero Scientifico Editore, Roma, 1997.

Zappa M. , Castiglione G. , Grazzini G. , Falini P. , Giorgi D. , Paci E. , Ciatto S. : Effect of faecal occult blood testing on colorectal cancer mortality: results of a population-based case-control study in the district of Florence, Italy. Int. J. Cancer, 73: 208–210, 1997.